Cognition Therapeutics Inc.

NASDAQ: CGTX
Share price (12/20/24): $0.63
Market cap (12/20/24): $26.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement with pricing info

Shelf registration

Ownership Filter

BIOS Memory SPV II, LP, BIOS Fund II NT, LP, BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LP, Cavu Management, LP, Cavu Advisors, LLC, BP Directors, LP, Kreis Leslie W., BIOS Equity Partners III, LP

BIOS Memory SPV I, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II QP, LP, Fletcher Aaron G.L., Bios Equity Partners II, LP, Bios Equity Partners, LP, BIOS Advisors GP, LLC, BIOS Capital Management, LP

Khattar Jack A.

Richstone Ellen B

News Filter

Investor Presentation

Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

Investor Presentation

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission